Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers. U19-HIPC Vaccination and Infection: Indicators of Immunological Health and Responsiveness

Trial Profile

Tissue-specific Responses to Influenza Immunization and Their Relation to Blood Biomarkers. U19-HIPC Vaccination and Infection: Indicators of Immunological Health and Responsiveness

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 15 May 2017

At a glance

  • Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Acronyms SLVP032
  • Most Recent Events

    • 20 Jan 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top